Developing best-in-class medicines to treat cancer - Karus Therapeutics

KA2507 highly-selective inhibitor of HDAC6. KA2237 dual-selective inhibitor of PI3K-p110β and p110δ. KA2507 highly-selective inhibitor of HDAC6. KA2237 dual-selective inhibitor of PI3K-p110β and p110δ. A new paradigm in cancer treatment combining the effectiveness of targeted therapy and immunotherapy. We have applied our insights into the structure and biological function of individual PI3K and HDAC enzymes to. KA2237 Phase I. KA2237 is a potent, dual-selective inhibitor of the p110β an.

OVERVIEW

The website karustherapeutics.com currently has an average traffic ranking of zero (the lower the more users). We have examined fifteen pages within the domain karustherapeutics.com and found six websites interfacing with karustherapeutics.com. There is two contacts and locations for karustherapeutics.com to help you contact them. The website karustherapeutics.com has been on the internet for six hundred and ninety-one weeks, twenty-nine days, seventeen hours, and thirty-two minutes.
Pages Crawled
15
Links to this site
6
Contacts
2
Addresses
2
Online Since
Apr 2011

KARUSTHERAPEUTICS.COM TRAFFIC

The website karustherapeutics.com has seen diverging levels of traffic for the duration of the year.
Traffic for karustherapeutics.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for karustherapeutics.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for karustherapeutics.com

Date Range

All time
This Year
Last Year
Last Month

KARUSTHERAPEUTICS.COM HISTORY

The website karustherapeutics.com was started on on April 08, 2011. It was last updated on the date of March 25, 2014. It will expire on the date of May 24, 2016. As of today, it is six hundred and ninety-one weeks, twenty-nine days, seventeen hours, and thirty-two minutes young.
REGISTERED
April
2011
UPDATED
March
2014
EXPIRED
May
2016

PERIOD

13
YEARS
2
MONTHS
29
DAYS

LINKS TO DOMAIN

Howards Blog

I attended the Society of Chemical Industry. 8216;s one day conference on the bang-up-to-date topic of Drug Discovery Outsourcing. Dr Alan Moodie, GSK. Dr Luigi La Vecchia, Novartis. Dr Andy Morley, AstraZeneca.

Novo AS Novo AS

We use cookies on this website. By using the website you accept our use of cookies. Is the holding company for the Novo Group. Great ideas need nurture and know-how to grow strong. An active partner with an international platform and long-term commitment. Creating value by holding rather than by exiting. Financial investments based on a clear investment philosophy.

Wyvernfund.com - Home

Is a source of seed and growth capital for early stage technology companies associated with our university partners. The Universities of Bristol and Southampton are leading research institutions and sit at the centre of a science and technology ecosystem which includes the SETsquared Partnership. And the Wyvern Seed Fund. Perpetuum wins contract to supply. Engine Shed, Clock Tower Yard, Temple Meads, Bristol, BS1 6QH.

Angels 5k - Active Investors Supporting UK Entrepreneurs

A Personal View Of Angels 5K. Criteria For Investing In Your Business. Investing Our Time and Money In Entrepreneurs. Looking For Investment from Angels 5K? If you can demonstrate both a high growth opportunity and a compelling business case, we will be pleased to hear from you. Would You Like To Join.

WHAT DOES KARUSTHERAPEUTICS.COM LOOK LIKE?

Desktop Screenshot of karustherapeutics.com Mobile Screenshot of karustherapeutics.com Tablet Screenshot of karustherapeutics.com

CONTACTS

Karus Therapeutics Ltd

2 Venture Road

Southampton, Hampshire, SO16 7NP

UK

Karus Therapeutics Ltd

Karus Therapeutics Ltd

2 Venture Road

Southampton, Hampshire, SO16 7NP

UK

KARUSTHERAPEUTICS.COM SERVER

I observed that a lone page on karustherapeutics.com took seven hundred and ninety-seven milliseconds to come up. Our web crawlers could not find a SSL certificate, so therefore our parsers consider this site not secure.
Load time
0.797 secs
SSL
NOT SECURE
Internet Protocol
134.0.20.66

NAME SERVERS

ns27.worldnic.com
ns28.worldnic.com

BROWSER IMAGE

SERVER OS

We identified that this domain is employing the Apache operating system.

HTML TITLE

Developing best-in-class medicines to treat cancer - Karus Therapeutics

DESCRIPTION

KA2507 highly-selective inhibitor of HDAC6. KA2237 dual-selective inhibitor of PI3K-p110β and p110δ. KA2507 highly-selective inhibitor of HDAC6. KA2237 dual-selective inhibitor of PI3K-p110β and p110δ. A new paradigm in cancer treatment combining the effectiveness of targeted therapy and immunotherapy. We have applied our insights into the structure and biological function of individual PI3K and HDAC enzymes to. KA2237 Phase I. KA2237 is a potent, dual-selective inhibitor of the p110β an.

PARSED CONTENT

The website karustherapeutics.com has the following on the web page, "KA2237 dual-selective inhibitor of PI3K-p110β and p110δ." We analyzed that the webpage also said " KA2507 highly-selective inhibitor of HDAC6." It also stated " KA2237 dual-selective inhibitor of PI3K-p110β and p110δ. A new paradigm in cancer treatment combining the effectiveness of targeted therapy and immunotherapy. We have applied our insights into the structure and biological function of individual PI3K and HDAC enzymes to. KA2237 is a potent, dual-selective inhibitor of the p110β an."

ANALYZE OTHER DOMAINS

karusuman DeviantArt

Deviant since May 28, 2003. This is the place where you can personalize your profile! By moving, adding and personalizing widgets. You can drag and drop to rearrange. You can edit widgets to customize them.

山口県美祢市 秋吉台国定公園 観光情報

46 金 美祢市市制施行10周年記念 AUN Jクラシックオーケストラ コンサート 2018 in 山口. 47 土 美祢市市制施行10周年記念 第31回みね桜祭り わっしょい桜. 1117 金 19 日 秋吉台星空のイルミネーション 秋芳洞カラーLED 光響ファンタジー. 210 土 出張萌えサミット2018 in 秋芳洞.

Karuszo - Bemutatkozás

Kara Zsolt testnevelő, úszásoktató vagyok. óta tevékenykedek a helyi Tanuszodában,. Független képviselőként 10 esztendeje segítem az. 214;nkormányzatot a kistelepülések fennmaradásáért folytatott.